Search

everythinglearnresearchcommunity

for

Search:↓

Certain medications can cause serious side effects, so it's important to report them.

A cream with a specific hormone blocker increases hair growth in mice.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Baricitinib is an effective treatment for severe alopecia areata.

Baricitinib is a safe and effective treatment for severe alopecia areata.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

The new microrhizotron tool effectively observes and measures pepper plant roots non-destructively.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

The topical solution increased hair count but wasn't significantly better than placebo in other measures.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

Diphenylcyclopropenone's effectiveness and safety for alopecia areata are unclear.

ITK inhibitors may effectively treat alopecia areata.

Very-long-chain acyl-CoA synthetases and fatty acid transport proteins play key roles in fatty acid metabolism and lipid processing in different tissues.

Andrographolide from Andrographis paniculata promotes hair growth and could be a natural treatment for hair loss.

The new nanocarriers improve how well water-insoluble drugs dissolve and allow for controlled drug release.

AI-09 is safe, effective, and reduces wrinkles for up to 6 months.

Vitamin C derivative helps hair grow longer by making cells produce a growth factor through a specific cellular pathway.

Physcion may help treat hair loss by blocking an enzyme linked to baldness.

Artificial hair fibers improve drug delivery accuracy through skin models.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

The DNN-DTIs method accurately predicts drug-target interactions and is useful for drug repositioning.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Baricitinib effectively reduces hair loss in severe alopecia areata and is generally safe.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Promising cancer treatments were found, but the manufacturer closed.